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Purpose: The aim of this study was to assess surgical, oncologic and functional results after robotic-assisted laparoscopic radical 
prostatectomy (RALP) with and without previous transurethral resection of the prostate (TURP). 
Methods: Between December 2005 and January 2010, 200 patients underwent RALP, of whom 16 (8%) had received previous TURP 
and 184 (92%) had not. Perioperative and postoperative data were compared between those with previous TURP (group 1) and those 
without previous TURP (group 2). All patients included in the study had at least 1-year follow-up. 
Results: Preoperative clinical parameters were comparable between both groups. Group 1 patients were found to have significantly 
more need for bladder neck reconstruction (93.75 % vs. 15.21%, P<0.001), more rectal injury (18.75% vs. 0%, P<0.001), higher 
incidence of major complications (18.8% vs. 1.1%, P<0.001), and smaller specimen volume (31.63 mL vs. 45.49 mL, P<0.001) than 
group 2. The 12-month continence rate was 93.8 % in group 1 and 97.8% in group 2 (P=0.344). A nerve-sparing technique was 
significantly less successfully performed in group 1 patients than in group 2 (33.3% vs. 92.0 %, P=0.001). 
Conclusions: Performing RALP for prostate cancer in patients who have had previous TURP is a technically demanding procedure 
and may be potentially associated with a higher perioperative major complication rate in short-term follow-up. Neurovascular bundle 
preservation is technically more challenging.
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INTRODUCTION
Incidental cancer of the prostate is found in 3%–16% of speci-
mens from transurethral resection of the prostate (TURP) 
[1,2]. The results of open radical retropubic prostatectomy 
(RRP) or laparoscopic radical prostatectomy (LRP) for pros-
tate cancer after previous TURP have been evaluated [3-
11]. The reports are conflicting as to whether or not previous 
TURP worsens the prognosis after radical prostate surgery as 
a result of fibrous scarring and altering of tissue layers associ-
ated with difficult surgical procedures.
 Since 2000, use of the da Vinci robotic system (Intuitive 
Surgical, Sunnyvale, CA, USA) has allowed the worldwide 
spread of RALP. The advantages of surgical robotics include 
three-dimensional visualization, seven degrees of freedom 
with instrument movement and absence of the fulcrum ef-
fect of conventional laparoscopy. However, limited data are 
available regarding robotic-assisted laparoscopic radical 
prostatectomy (RALP) after previous TURP [12-14]. In our 
previous study [15], we found that learning curve to decrease 
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including specimen volume, tumour volume, tumour per-
centage, Gleason score, positive surgical margin (PSM) rate, 
and nodal status. Perioperative complications over the 180-
day postoperative period were evaluated and graded from 
grade 0 to grade V according to the Clavien-Dindo classifica-
tion system [19]. Grade I to grade II were considered as minor 
complications, while grade III to grade V were classified as 
major complications.
 Continence was defined as having no pad use. Potency was 
defined as achieving sufficient erection to intercourse with or 
without phosphodiesterase 5 inhibitor. Postoperative potency 
and continence data for up to 12 months were assessed and 
recorded. PSA or biochemical failure was regarded as two se-
rial serum PSA results > 0.2 ng/mL [20].
 The preoperative, intraoperative, and postoperative data 
were collected, and the results were retrospectively compared 
between the patients with a history of resection (group 1) and 
those without previous TURP (group 2).
2. Statistical analysis
A retrospective cross-sectional evaluation of surgical, onco-
logic and functional results was made to compare groups 1 
and 2. The SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA) was 
used for the statistical analyses. Statistical analysis was car-
ried out using the independent sample t-test & chi-square 
test. In all tests, P< 0.05 was considered to indicate statistical 
significance.
RESULTS
As shown in Table 1, a total of 200 patient charts were re-
viewed, identifying 16 patients with previous TURP (group 1) 
and 184 without previous TURP (group 2). In group 1, there 
were three patients with benign pathology in the previous 
TURP specimens but prostate cancer was discovered during 
subsequent follow-up. The other 13 patients had prostate 
cancer incidentally identified in TURP chips. No significant 
differences were found between the two groups in age, BMI, 
ASA risk class, clinical stage, mean preoperative PSA level, 
free PSA, PSA density or Gleason grade from the biopsies. 
However, the biopsy percentage was higher in group 1 than in 
group 2 (33.4% vs. 21.6%, P= 0.003).
 Table 2 reveals the intraoperative data and complica-
tions. The need for bladder neck reconstruction was signifi-
cantly greater in group 1 than in group 2 (93.75% vs. 15.21%, 
P< 0.001). Rectal injury was higher in group 1 compared to 
group 2 (18.75% vs. 0%, P< 0.001). More major complica-
tions occurred in group 1 than in group 2 (18.8% vs. 1.1%, 
major complications of RALP is significantly decreased after 
150 cases. Nevertheless, RALP in patients with previous TURP 
tended to be more technically difficult and potentially associ-
ated with more perioperative complications. Hence, the aim 
of the present study was to examine whether previous TURP 
affects the oncologic safety, functional efficacy and complica-
tion rates of RALP.
MATERIALS AND METHODS
1. Patients and procedure
From December 2005 to January 2010, 200 consecutive pa-
tients with prostate cancer underwent RALP by a single sur-
geon (Y.C.O.) at our institution. RALP was performed after a 
minimum of 6 weeks after biopsy and 12 weeks after TURP. 
Among 200 RALPs performed, 16 patients (8%) had received 
previous TURP (group 1) and 184 patients (92%) had not. 
Recorded preoperative clinical characteristics included age, 
body mass index (BMI), American Society of Anesthesiolo-
gists anesthetic/surgical risks class (ASA), prostate-specific 
antigen (PSA) levels, PSA density, biopsy percentage, biopsy 
Gleason score and clinical stage (using the 2002 American 
Joint Committee on Cancer stage). 
 Transperitoneal RALP was performed as previously de-
scribed [15-17]. Dissection of the bilateral pelvic lymph nodes 
(BPLND) was usually performed and only excluded in low-
risk patients with a low likelihood ( < 3%) of lymph node posi-
tivity. Neurovascular bundle (NVB) sparing procedures using 
the Vattikuti Institute Prostatectomy technique [18] were per-
formed depending on preoperative tumour status and each 
patient’s choice. For low risk patients, bilateral NVB preserva-
tion was tried. For intermediate risk patients, unilateral NVB 
preservation was tried. And no NVB preservation will be 
attempted for high risk patients. Urethrovesical anastomo-
sis was made utilizing two 18-cm 3–0 Monocryl continuous 
stitches. An 18-French silicon Foley catheter with a 10-mL 
balloon was placed. The urinary bladder was then filled with 
200 mL normal saline to check for watertight anastomosis.
 Intraoperative and perioperative parameters were record-
ed for each surgery including performance of BPLND, type 
of NVB preservation (i.e., none, unilateral, bilateral), vesico-
urethral anastomosis time, surgeon’s console time, estimated 
blood loss, transfusion rate and complications up to 180 days 
postoperatively. Console time was defined as the time inter-
val while the surgeon was sitting at the surgical console using 
the daVinci system during the entire operation. Specimens 
were fixed, Indian ink-coated and serially perpendicular sec-
tioned at 4-mm intervals. Oncologic results were recorded, 
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P< 0.001). Console time, vesicourethral anastomosis time and 
surgical complication rate were slightly increased in group 1, 
although no statistically significant difference existed.
 Outcome analysis is shown in Table 3. There was mild in-
crease in the length of hospital stay and duration of bladder 
catheterization in group 1, but differences were not statistically 
significant. Mean prostate specimen volume was significantly 
greater in group 2 than in group 1 (31.63 mL vs. 45.49 mL, 
P<0.001).
 The oncological outcomes are also reported in Table 3. 
Pathological stages were distributed similarly between the 
two groups. The combined, overall PSM rate for all patients 
regardless of pathologic stage was 43.8% and 40.2% in groups 
1 and 2, respectively (P= 0.992). The pathological Gleason 
score and node positive rate were similar in the two groups. 
During the first year after RALP, the PSA level was measured 
every 3 months in all patients; at 1 year after RALP three of 16 
patients (18.8%) after TURP and RALP, and 21 of 184 (11.4%) 
after RALP only (P= 0.416) had a PSA recurrence.
 NVB preservation and functional results are presented in 
Table 4. The continence rate was slightly decreased in group 
1 than in group 2 at 1 week, 1 month, 3 months, 6 months, 
and 12 months after RALP, although no statistically signifi-
cant difference was observed. A nerve-sparing procedure 
Table 1. Preoperative characteristics, preoperative variables 
during robotic-assisted laparoscopic prostatectomy in the two 
groups
Variable
TURP
P-valueGroup 1 
(Yes, n=16)
Group 2 
(No, n=184)
Age (yr) 67.5±7.4 64.8±6.9 0.134
Body mass index (kg/m2) 25.2±3.5 24.5±2.8 0.400
ASA physical status 
   classification system
0.112
   1 0 (0) 40 (21.7)
   2 14 (87.5) 128 (69.6)
   3 2 (12.5) 16 (8.7)
PSA (ng/mL) 26.44±29.59 17.85±20.27 0.271
Free PSA (ng/mL) 3.51±4.71 2.02±2.20 0.080
PSA density 0.67±0.54 0.52±0.57 0.333
Biopsy percentage 33.4±26.0 21.6±20.5 0.032
Gleason score 6.63±1.02 6.59±1.08 0.892
Clinical stage 0.451
   T1 8 (50.0) 71 (38.6)
   T2 8 (50.0) 101 (54.9)
   T3 0 (0) 12 (6.5)
Values are presented as mean±standard deviation or number (%).
TURP, trans-urethral resection of prostate; ASA, American Society of 
Anesthesiologists; PSA, prostate-specific antigen.
Table 2. Patient perioperative data and complications using 
the Clavien classification systema)
Variable
TURP
P-valueGroup 1 
(Yes, n=16)
Group 2 
(No, n=184)
Vesicourethral anastomosis (min) 32.6±19.9 30.3±10.2 0.432
Need for reconstruction of
   bladder neck 
15 (93.75) 28 (15.21) <0.001
Console time (hr) 3.16±1.74 2.95±0.78 0.367
Blood loss (mL) 145.0±161.4 183.2±18.06 0.416
Transfusion 0 (0) 7 (3.8) 1.000
BPLND 14 (87.5) 153 (83.2) 1.000
Complications 4 (25.0) 20 (10.9) 0.108
  Clavien grade I 1 (25.0) 5 (25.0) 0.004
  Clavien grade II 0 (0) 13 (65.0)
  Clavien grade III 1 (25.0) 2 (10.0)
  Clavien grade IV 2 (50.0) 0 (0)
  Minor (Clavien grade I–II) 1 (6.3) 18 (9.8) <0.001
  Minor (Clavien grade III–V) 3 (18.8) 2 (1.1)
  No complication 12 (75.0) 164 (89.1)
  Rectal injury 3 (18.75) 0 (0) <0.001
  Anastomosis stricture 0 (0) 2 (1.08) 1.000
Values are presented as mean±standard deviation or number (%).
TURP, trans-urethral resection of prostate; BPLND, bilateral pelvic 
lymph node dissection.
a)Clavien system: grade I, deviate from the normal postoperative course 
without treatment; grade II, drug or bedside treatment; grade III, endo-
scopic (IIIa) or surgical intervention (IIIb); grade IV, life-threatening prob-
lem, single organ (IVa) or multiorgan (IVb); grade V, death; minor, I–II; 
major, III–V.
Table 3. Patient postoperative and oncologic results
Variable
TURP
P-valueGroup 1 
(Yes, n=16)
Group 2 
(No, n=184)
Foley catheter (day) 9.31±2.82 9.00±2.57 0.644
Postoperative stay (day) 4.19±2.01 3.77±2.26 0.477
Pathology stage
pT2 4 (25.0) 74 (40.2) 0.128
pT3 10 (62.5) 104 (56.5)
pT4 2 (12.5) 6 (3.3)
Surgical margin positive 7 (43.8) 74 (40.2) 0.992
pT2 1 (25.0) 4 (5.4) 0.610
pT3 4 (40.0) 64 (61.5) 0.199
pT4 2 (100) 6 (100)
Specimen volume (mL) 31.63±8.82 45.49±20.99 <0.001
Tumor volume 7.43±6.88 11.05±11.73 0.226
Tumor percentage 22.81±21.21 25.86±24.47 0.631
Pathology Gleason score
2–4 0 (0) 2 (1.1) 0.179
5–7 16 (100) 151 (82.1)
8–10 0 (0) 31 (16.8)
Node positive 1 (6.3) 12 (6.52) 1.000
PSA failure 3 (18.8) 21 (11.4) 0.416
Values are presented as mean±standard deviation or number (%).
TURP, trans-urethral resection of prostate; PSA, prostate-specific anti-
gen.
Vol. 2 / No. 2 / June 2014
85
PROSTATE INTERNATIONAL
http://dx.doi.org/10.12954/PI.14046
was attempted in 37.5% of patients in group 1 and 47.8% in 
group 2, separately (P= 0.594). Moreover, NVB preservation 
was successfully performed in only 33.3% of group 1 patients, 
compared with 92.0% of group 2 patients (P= 0.001). The NVB 
seemed to be less able to be free from the prostatic capsule af-
ter previous TURP. In group 1, two patients had bilateral NVB 
preservation and had potency after 12 months. In group 2, 65 
patients had potency after 12 months, including 17 who had 
unilateral NVB preservation and 48 who had bilateral NVB 
preservation.
DISCUSSION
After the introduction of PSA measurement and the increas-
ing use of transrectal ultrasound-guided biopsies, the fre-
quency of detected prostate cancer at prostate chips during 
TURP has decreased [21]. The results from different series of 
open, laparoscopic and robot-assisted prostatectomies after 
Table 5. Surgical, oncologic and functional results after open radical retropubic prostatectomy (RRP), laparoscopic radical prostatec-
tomy (LRP), extraperitoneal laparoscopic radical prostatectomy (ELRP) and robotic-assisted radical prostatectomy (RALP) with and 
without previous transurethral resection of the prostate (TURP) in the literature
Investigator Technique
Perioperative outcome & 
complication rate
Oncological outcome Functional outcome
Palisaar et al. [3]     RRP No higher complication rate Insignificantly higher
   PSM rate and PSA failure rate
Similar complete urinary control 
   rate 
Similar potency rate when nerve
   preserved
Colombo et al. [4]     RRP Longer operative time  
Increased morbidity rate
Insignificantly higher
   PSM rate and PSA failure rate
Less satisfactory functional
   results
Do et al. [6]     ELRP Comparable perioperative outcome
Higher complication rate
Comparable oncological
   outcome
Similar continence rate 
Lower potency rate
Teber et al. [7]     LRP Longer operative time
Comparable complication rate 
Comparable oncological
   outcome
Delayed continence time 
Unaffected potency rate if nerve 
   sparing
Menard et al. [8]     LRP Worse perioperative outcome 
Higher surgical complicate rate
Comparable oncological
   outcome
Similar continence rate
More difficult NVB preservation
Similar potency rate when nerve   
   preserved
Jaffe et al. [9]     LRP Longer operative time, length of stay
Higher overall complicate rate
Higher PSM rate NR
Eden et al. [10]     LRP Longer catheterization time  
No difference in complication rate
Similar PSM rate
Similar biochemical
   recurrence rate
Delayed continence time
No difference in erection rates
Martin et al. [12]     RALP Longer catheterization time  
No difference in complication rate
Similar PSM rate NR
Gupta et al. [13]     RALP Greater blood loss and a need for
    bladder neck reconstruction
Higher PSM rate   
Higher biochemical recurrence 
rate
Higher incontinence rate
Zugor et al. [14]     RALP More need for bladder neck reconstruction  
Longer operative time More minor complicate rate
Comparable PSM rate Delayed continence and potency
   time
Present study     RALP More need for bladder neck reconstruction  
More rectal injury and major complications  
More difficulty in the NVB preservation
Comparable PSM rate and PSA 
   recurrence rate
Similar continence rate 
More difficult NVB preservation
PSM, positive surgical margin; PSA, prostate-specific antigen; NR, not recorded; NVB, neurovascular bundle.
Table 4. Functional results after RALP and neurovascular bun-
dle preservation
Variable
TURP
P-valueGroup 1 
(Yes, n=16)
Group 2 
(No, n=184)
Continence within
1 Week 4 (25.0) 72 (39.1) 0.396
1 Months 9 (56.3) 114 (62.0) 0.855
3 Months 14 (87.5) 172 (93.5) 0.310
6 Months 15 (93.8) 179 (97.3) 0.398
12 Months 15 (93.8) 180 (97.8) 0.344
Attempt to NVB preservation 6 (37.5) 88 (47.8) 0.594
Successful NVB preservation 2 (33.3) 81 (92.0) 0.001
Incidence NVB preservation 2 (12.5) 81 (44.0) 0.029
Potency at 12 months 2 (100) 65 (80.3) 1.000
Bilateral NVB 2 (100) 48 (73.8) 1.000
Unilateral NVB 0 (0) 17 (26.2)
Values are presented as number (%).
RALP, robotic-assisted radical prostatectomy; TURP, transurethral resec-
tion of prostate; NVB, neurovascular bundle.
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TURP in the literature are summarized on Table 5. The effects 
of previous TURP on open RRP are controversial. Palisaar et 
al. [3] used a case-controlled design to match 62 cases (with 
previous TURP) with an equivalent number of controls (with-
out previous TURP). Matching parameters included patient 
age, BMI, prostate volume, preoperative PSA level, Gleason 
score, pathological stage and nerve-sparing procedure. After 
complete 1-year follow-up, they reported that previous TURP 
does not cause a higher perioperative complication rate nor 
a worse functional result. The overall PSM rates and one-year 
biochemical recurrence rates were comparable in their study. 
 Colombo et al. [4] examined 109 patients who had RRP 
for prostate cancer, all of whom had previous operation for 
bladder outlet obstruction. Among 88 of these 109 patients, 
the previous intervention was TURP. They reported that RRP 
could be safely undertaken with slightly increased morbid-
ity after previous prostate surgery, but erectile function and 
urinary continence were compromised in contrast to patients 
with no previous treatment.
 The effect of previous TURP on LRP is also debated. Do et 
al. [6] stated that 100 of 2,300 patients had endoscopic extra-
peritoneal radical prostatectomy after previous TURP. That 
procedure is technically more challenging, but perioperative, 
functional and short-term oncologic outcomes are promising 
and are directly equal to outcomes without previous TURP. 
However, the potency results were inferior in the patients with 
previous TURP.
 Teber et al. [7] described outcomes of LRP in clinical T1a 
and T1b prostate cancer. They reported that LRP is oncologi-
cally safe. The recovery to total continence was delayed, but 
the potency rates remained unaffected if a nerve-sparing pro-
cedure was executed. Menard et al. [8] revealed that LRP after 
TURP would not hinder the oncologic results, but that it was 
related to poorer intraoperative and postoperative outcomes. 
Also, NVB preservation was technically more difficult and 
negatively affected postoperative erectile function.
 Jaffe et al. [9] described poorer surgical outcomes in men 
undergoing LRP after TURP, inclusive of operative time, 
length of stay, PSM rate, and overall complication rate but 
without mentioning the functional results. However, Eden et 
al. [10] reported the functional results after LRP in patients 
with previous bladder outlet surgery, and did not find any dif-
ference even in the nerve-sparing procedures. 
 As for RALP, few results are reported comparing RALP 
outcomes in patients with and without previous prostate 
treatment. Martin et al. [12] evaluated 24 patients receiving 
RALP who had a history of previous treatment to the pros-
tate compared to 486 men without previous treatment and 
concluded that a history of previous treatment of the prostate 
does not seem to compromise the perioperative outcomes 
of RALP. Gupta et al. [13] compared outcomes of RALP in 26 
patients with TURP to 132 cases of RALP without TURP and 
discovered a longer operating time, higher operative difficulty 
and hampered oncological or continence outcomes. Zugor 
et al. [14] used a match-paired analysis to compare 80 cases 
with previous TURP with an equivalent number of controlled 
patients and reported that technically more demanding, a 
prolonged operative time and time interval before continence 
and potency returns in patients with a previous TURP. But it 
can be safely performed without compromising functional 
results. Our results found significant increase in the need of 
bladder neck reconstruction, more rectal injury, major com-
plications and difficulty in the NVB preservation procedure in 
the patients receiving RALP with previous TURP.
 In the literature describing open RRP or LRP after TURP, 
most authors described the procedure as being more difficult 
[4-8]. Perforation of the prostatic capsule during TURP with 
extravasation of blood and irrigation fluid can result in peri-
prostatic fibrosis and distortion of the surgical planes [4,5]. 
We observed increased need for bladder neck reconstruc-
tion, more vesicourethral anastomosis time, console time, 
catheter duration, hospital stay, major complication rate and 
less chance to successful NVB preservation in the patients 
who had previously undergone TURP, probably suggesting 
the suspicion that prior TURP does add to the complexity of 
RALP, although these did not reach statistical significance 
except for the need for bladder neck reconstruction, rectal 
injury, major complication rate and successful rate of NVB 
preservation.
 In our experience, the three cases with rectal injuries oc-
curred in cases #81, 125, 129, with none observed in the first 
50 patients [22]. The operative difficulties were mainly en-
countered during identification of the anterior bladder neck, 
resection of the posterior part of the bladder neck and when 
starting dissection of the posterior plane of the prostate. Tech-
nical difficulties were also encountered during dissection of 
the apex and identification of the urethral stump; however, it 
is less likely to objectively quantify these parameters. To avoid 
rectal injury in RALP, dissection of the prostatic apex should 
be made carefully and sharply with cold scissors instead of 
an electrical energy source to prevent thermal damage. Also, 
the rectum should be hold posteriorly by the assistant during 
dissection the recto-urethral muscle from the posterolateral 
angle. In addition, it is mandatory to adequately incise the 
posterior layer of Denovillier’s fascia to avoid false entry into 
the perirectal fat after completing dissection of both seminal 
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vesicles. Previous TURP results in a wide bladder neck, which 
can sometimes be very close to the ureteral orifices, suggest-
ing that these structures could be easily injured during dissec-
tion of the posterior bladder neck. In an attempt to visualize 
the ureteral orifices by insertion of double-J stents bilaterally, 
ureteral injury can be avoided [6]. In the first two cases of 
group 1, double-J stents were inserted to clearly identify the 
ureteral orifices; however, in the following cases, we were 
more confident to identify the ureteral orifices under direct 
vision from robotic laparoscope and did not insert double-J 
stents. A wider bladder neck also increased the time of blad-
der neck sparing and bladder neck reconstruction (tennis 
racket method) during vesicourethral anastomosis.
 Do et al. [6] and Menard et al. [8] performed LRP at least 
3 months after the TURP procedure since, by that time, the 
periprostatic inflammation caused by the TURP had prob-
ably subsided and conditions in the operative field would 
have been more favourable. Elder et al. [23] recommended 
that radical perineal prostatectomy should be performed 
during the first month after TURP or after a time interval of 4 
months. In our series, RALP was routinely carried out after a 
minimum of 6 weeks post biopsy and 12 weeks post TURP.
 A statistically significant difference was observed between 
group 1 and group 2 in this study in the weight of the prostatic 
specimens (31.63 mL vs. 45.49 mL, respectively, P<0.001). This 
result seems to be in contrast to the data from other reports 
[8,9]. Jaffe et al. [9] suggested that patients with a history of 
TURP have larger prostates that, after resection, are then simi-
lar to the size of prostates in men who did not undergo TURP. 
In our series, this result may be due to much more prostate tis-
sue removed when TURP. 
 Oncological outcome is the primary end-point for patients 
with prostate cancer receiving radical prostatectomy. The 
technical difficulties did not seem to have much influence in 
the short-term oncologic outcomes after RALP for the patients 
with previous TURP, as shown by the overall PSM rate and the 
1-year biochemical failure rate. In the current series, the PSM 
rate for pT2, pT3, and pT4 patients was 25%, 40%, and 100%, 
respectively, and the overall PSM rate was 43.8% in patients 
with previous TURP. Other series of LRP and RALP in patients 
with previous prostate treatment reported overall PSM rates 
of 6.25%–26.1% [6,8-10,12-14]. PSM frequency is influenced 
by surgical technique (procedure, ability and experience), 
tumour features (size, aggressiveness, extension) and patho-
logical analysis [24]. PSM rates in our study seem to be higher 
compared to other series. This may be explained as a result 
of our surgical population having higher PSA results and a 
higher incidence of high-risk patients than in other series.
 In terms of functional outcomes, our data revealed no sta-
tistical significance in continence and potency results among 
two groups. Although statistically significant differences were 
not observed in preoperative PSA levels and preoperative 
Gleason scores between the groups with and without previ-
ous TURP, the isolation and preservation of the NVBs was 
technically feasible in only 33.3% of patients after TURP, com-
pared to 92.0% in the patients without previous TURP. The 
nerve sparing technique appeared to us to be more difficult 
in patients with previous TURP, and many investigators con-
cur [4,6,8]. This difficulty results from greater tissue reaction 
and periprostatic fibrosis caused by fluid extravasation dur-
ing TURP. However, we demonstrated that potency could be 
achieved if a nerve-sparing procedure was possible after pre-
vious TURP. The aetiology of erectile dysfunction after radical 
prostatectomy is multifactorial, and neurogenic factors and 
thermal injury seem to play a crucial role [8,25]. Therefore, 
a history of TURP should also be viewed as a risk factor for 
erectile dysfunction after RALP.
 Patient age, preoperative International Prostate Symptom 
Score (IPSS) and anastomotic stricture development were 
considered to be independent risk factors for incontinence 
after radical prostatectomy [8,26]. Nevertheless, Kessler et al. 
[27] showed a significant effect of nerve-sparing surgery on 
urinary continence. We observed differences between the 
TURP and non-TURP groups with regard to the nerve sparing 
procedures, but the continence rates were somewhat lower 
in patients with previous TURP at 1 week, 1 month, 3 months, 
6 months and 12 months after RALP, even though no signifi-
cant differences were found.
 The present study has several limitations and study results 
should be carefully interpreted. First and most important, this 
is a small series and there were significantly fewer patients 
in group 1 than in group 2. Second, this was a retrospective 
study and the time interval between TURP and RALP was not 
consistent, which could be an important variable, substan-
tially contributing to the degree of periprostatic inflammation 
and scarring over time. Third, the technical difficulties, (e.g., 
identification of anterior bladder neck, resection of posterior 
part of bladder neck, and dissection of posterior plane of 
prostate) are hard to objectively quantify; therefore, is defi-
nitely a limitation of this study. Fourth, we know that the post-
operative functional results should have employed validated 
questionnaires and that the lack of preoperative continence 
and erectile function status determination might introduce 
bias into the analysis. Fifth, a multi-institutional study with 
more long-term and large-scale data, including rates of PSA 
failure, continence and potency, are needed to examine the 
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efficacy of RALP in the patients with previous TURP.
  In conclusion, previous TURP represents a technical chal-
lenge for performing RALP, and the perioperative results, the 
incidence of major complications and short-term functional 
outcomes of RALP may be inferior to those of patients with-
out TURP. NVB preservation is more technically demanding. 
We suggest that these potential risks should be clearly ex-
plained to patients with history of TURP who are candidates 
for RALP and the procedure should be handled by an experi-
enced robotic surgeon.
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